Malcolm R Alison

Lady Pohamba Private Hospital, Windhoek, Namibia.

50 publications 2010 – 2025 ORCID

What does Malcolm R Alison research?

Malcolm R Alison studies the use of human umbilical cord stem cells for treating bowel diseases, specifically inflammatory bowel diseases. His research involves experimenting on mice with weakened immune systems to see how these stem cells can help reduce inflammation in the intestines. By exploring this new treatment avenue, Alison aims to provide better options for patients suffering from severe digestive disorders.

Key findings

  • Injecting umbilical cord stem cells reduced inflammation levels in mice from 2.08 to 1.45.
  • Colon length in treated mice increased from 6.8 cm to 8.95 cm.
  • Overall disease severity improved significantly, indicating a positive impact of stem cell therapy on bowel health.

Frequently asked questions

Does Dr. Alison study inflammatory bowel diseases?
Yes, Dr. Alison focuses on using stem cells to treat inflammatory bowel diseases.
What treatments has Dr. Alison researched?
He has researched the use of umbilical cord mesenchymal stem cells as a potential treatment for bowel diseases.
Is Dr. Alison's work relevant to patients with bowel conditions?
Yes, his research could lead to new treatment options for patients suffering from inflammatory bowel diseases.

Publications in plain English

Clinical Profile and Management of Wolf-Parkinson White Syndrome and Asymptomatic Pre-Excitation Carriers in Africa: A Multicenter Pan African Registry From 17 Countries.

2025

Journal of cardiovascular electrophysiology

Allam L, Bekouti JT, Gabra MD, Shogade TT, El-Hariri HM +16 more

Plain English
This study looked at how Wolf-Parkinson White Syndrome (WPW) and other related heart arrhythmias are diagnosed and treated across Africa, using data from 20 medical centers in 17 countries. They found that among 541 participants, 93% had WPW syndrome, with the most common type of arrhythmia occurring in 55% of cases. The study highlighted that while radiofrequency ablation was used for 88% of patients as a long-term solution, treatment approaches varied significantly by region, showing that Northern and Southern African countries were more advanced in their management strategies compared to others. Who this helps: This research benefits patients with WPW syndrome by improving understanding and treatment options in different regions of Africa.

PubMed

Hepatocytes undergo punctuated expansion dynamics from a periportal stem cell niche in normal human liver.

2023

Journal of hepatology

Passman AM, Haughey MJ, Carlotti E, Williams MJ, Cereser B +14 more

Plain English
This study looked at how liver cells, called hepatocytes, grow and where they come from in healthy human livers. Researchers found that hepatocyte growth happens slowly and in specific patterns, usually starting near bile ducts, and sometimes these cells remain inactive for years before they grow. Understanding this process is important because it helps researchers figure out how changes in these cells can lead to liver diseases like cancer. Who this helps: This helps researchers and doctors working to prevent and treat liver conditions.

PubMed

Aldolase triggers metabolic reprogramming in colorectal cancer in hypoxia and stiff desmoplastic microenvironments.

2020

Colloids and surfaces. B, Biointerfaces

Huang HC, Lin WR, Lim SN, Yeh CT, Yen TH +2 more

Plain English
The study focused on how certain physical conditions, like low oxygen (hypoxia) and stiffness of the surrounding tissue, affect the metabolism of colorectal cancer (CRC) cells. Researchers found that when CRC cells were placed on stiff surfaces, glucose uptake and certain metabolic processes decreased, but adding a protein called aldolase B reversed this effect, leading to a 1.5 times increase in glucose uptake and 2 to 3 times increase in a specific type of energy production. This is important because it shows how changes in the tumor environment can alter cancer cell behavior and suggests that targeting metabolic pathways could be a potential treatment strategy for colorectal cancer. Who this helps: This helps patients with colorectal cancer and their doctors by opening avenues for new therapies.

PubMed

The cellular origins of cancer with particular reference to the gastrointestinal tract.

2020

International journal of experimental pathology

Alison MR

Plain English
This study looked at how cancer starts in the gastrointestinal tract, specifically focusing on stem cells and other related cells. Researchers found that mutations in certain genes can cause these cells to turn into tumors, with stem cells in specific areas of the esophagus, stomach, and intestines being the likely starting points for many cancers. This is important because understanding the origins can help in developing targeted treatments and prevention strategies for these cancers. Who this helps: This benefits patients at risk for gastrointestinal cancers and their doctors.

PubMed

The effect of prophylactic hemoclip placement and risk factors of delayed post-polypectomy bleeding in polyps sized 6 to 20 millimeters: a propensity score matching analysis.

2020

BMC gastroenterology

Chen CW, Kuo CJ, Chiu CT, Su MY, Lin CJ +5 more

Plain English
This study examined whether placing a preventive clip (called a hemoclip) on polyps during removal surgery (polypectomy) can reduce the risk of bleeding afterward, especially for polyps that are 6 to 20 millimeters in size. The results showed that using hemoclips did not significantly lower the chances of delayed bleeding, with rates at 0.8% for the clip group and 1.3% for the no-clip group. Factors that raised the risk of bleeding included larger polyp size, having multiple polyps removed, and using blood thinners. Who this helps: This information helps doctors determine when to use hemoclips for patients undergoing polyp removal.

PubMed

Bile ductular reactions in the liver: similarities are only skin deep.

2019

The Journal of pathology

Alison MR, Lin WR

Plain English
This study looked at changes in liver cells known as bile ductular reactions (DRs) in different liver diseases, particularly focusing on how these reactions vary between patients with Hepatitis C (HCV) and primary sclerosing cholangitis (PSC). Researchers found that DRs from HCV patients expressed 330 genes differently compared to those from PSC patients, which highlights how these reactions are unique to specific diseases and not just a general response to liver damage. Understanding these differences could lead to targeted treatments that either reduce liver damage or encourage healing. Who this helps: This benefits patients with liver diseases like HCV and PSC.

PubMed

Periportal SRY (Sex Determining Region Y)-Box 9-Positive Hepatocytes: Progenitors With a Biliary Leaning.

2019

Hepatology (Baltimore, Md.)

Alison MR, Lin WR

PubMed

Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas.

2019

EBioMedicine

Lin WR, Chiang JM, Lim SN, Su MY, Chen TH +10 more

Plain English
This study examined how energy production changes in adenomatous polyps (APs) and colorectal cancers (CRCs). Researchers found that while APs showed a significant increase in a process called glycolysis (measured by a 54% increase in acidification rate), CRCs had reduced ability to produce energy through a different process, oxidative phosphorylation, which was decreased by about 60%. Understanding these changes is important because they shed light on how these growths develop and worsen, potentially leading to better treatment strategies. Who this helps: This helps patients at risk for colorectal cancer and doctors treating them.

PubMed

An Immunopathological Evaluation of the Porcine Cholecyst Matrix as a Muscle Repair Graft in a Male Rat Abdominal Wall Defect Model.

2018

Toxicologic pathology

Balakrishnan-Nair DK, Nair ND, Venugopal SK, Das VN, George S +5 more

Plain English
This study looked at a new type of muscle repair graft made from pig gallbladder tissue (called porcine cholecyst-derived scaffold, or CDS) and compared its effects to other types of grafts in a rat model. The researchers found that CDS led to a favorable healing response, mainly driven by helpful immune cells, with less irritation than the other grafts tested. This matters because it shows CDS could be a promising option for muscle repair, potentially leading to better outcomes for patients needing such treatments, thanks to its compatibility with the body. Who this helps: This helps patients recovering from muscle injuries or surgeries.

PubMed

Macrophages come on tap for liver fibrosis therapy.

2018

Hepatology (Baltimore, Md.)

Alison MR, Lin WR

PubMed

The many ways to mend your liver: A critical appraisal.

2018

International journal of experimental pathology

Alison MR

Plain English
This research paper reviews how liver cells regenerate after injury or surgery, focusing on where stem cells that help with this process are located. Researchers found that there are several key areas in the liver where these stem cells exist, and some can become more active when the liver is damaged. Understanding these mechanisms is important because it can lead to better treatments for liver diseases and injuries. Who this helps: Patients with liver disease and doctors treating them.

PubMed

pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma.

2018

Oncoimmunology

Kuchuk O, Tuccitto A, Citterio D, Huber V, Camisaschi C +9 more

Plain English
This study looked at how certain substances that manage acidity in the environment around liver cancer cells (specifically hepatocellular carcinoma) can be used to improve treatment. Researchers found that specific molecules, called pH regulators, were present in high amounts in liver tumors and that blocking one of these, V-ATPase, made the tumor environment less supportive of cancer growth and more open to immune attack. This is significant because it suggests a new approach to making liver cancer treatments more effective by combining this strategy with existing immunotherapies. Who this helps: This helps patients with liver cancer by potentially improving their treatment options.

PubMed

Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury.

2018

Clinical science (London, England : 1979)

Bizzaro D, Crescenzi M, Di Liddo R, Arcidiacono D, Cappon A +13 more

Plain English
This study looked at how male and female bodies respond differently when the liver gets injured and tries to heal. Researchers found that male mice had a slower healing process and more inflammation compared to female mice. In particular, male mice had an increased number of immature immune cells, which may contribute to prolonged liver damage, and similar patterns were observed in male patients with liver injury. Who this helps: This research helps doctors better understand gender differences in liver injury and could improve treatment for patients experiencing liver damage.

PubMed

A gold nanoparticle coated porcine cholecyst-derived bioscaffold for cardiac tissue engineering.

2017

Colloids and surfaces. B, Biointerfaces

Nair RS, Ameer JM, Alison MR, Anilkumar TV

Plain English
This study looked at enhancing a type of scaffold made from pig gallbladder tissue (C-ECM) by adding gold nanoparticles to improve its surface structure for heart tissue engineering. The researchers found that the modified scaffold supported the growth of heart cells without being harmful, making it a suitable option for creating heart tissues. This matters because it could lead to better repairs or replacements for damaged heart tissue. Who this helps: This helps patients with heart issues and physicians working on cardiac repairs.

PubMed

Cholangiocytes: No Longer Cinderellas to the Hepatic Regenerative Response.

2017

Cell stem cell

Alison MR

Plain English
This study looked at how liver cells, specifically cholangiocytes (biliary ductal cells), behave when the liver is damaged. The researchers found that stopping the main liver cells from replicating is necessary for these cholangiocytes to help the liver heal. This discovery is important because it clarifies the role of these cells in liver recovery, which could lead to better treatments for liver diseases. Who this helps: Patients with liver damage.

PubMed

Cell lineage tracing in human epithelial tissues using mitochondrial DNA mutations as clonal markers.

2016

Wiley interdisciplinary reviews. Developmental biology

Walther V, Alison MR

Plain English
This study looked at how to trace the lineage of human cells using mutations in mitochondrial DNA, which accumulate over time in stem cells. Researchers found that when at least 80% of the mitochondrial DNA in a cell has the same mutation, it indicates that the cell and its descendants all originated from a common stem cell, allowing them to identify clonal populations. This method is significant because it helps better understand how normal tissues develop and how tumors can form by differentiating between healthy and diseased cells. Who this helps: This research benefits doctors and researchers studying cancer and tissue development.

PubMed

Diverse routes to liver regeneration.

2016

The Journal of pathology

Alison MR, Lin WR

Plain English
This study looked at how the liver can repair itself through different mechanisms. Researchers found that when the liver is damaged, various types of liver cells can help regenerate tissue: a specific group of cells called periportal hepatocytes becomes active, and liver progenitor cells (HPCs) can fully replace damaged liver tissue. This shows that the liver has multiple ways to heal itself, which is important for understanding treatments for liver diseases. Who this helps: This benefits patients with liver diseases by improving treatment options.

PubMed

Hepatocytes come out of left field.

2016

Hepatology (Baltimore, Md.)

Alison MR, Lin WR

PubMed

The Influence of Bone Marrow-Secreted IL-10 in a Mouse Model of Cerulein-Induced Pancreatic Fibrosis.

2016

BioMed research international

Lin WR, Lim SN, Yen TH, Alison MR

Plain English
This study looked at how a substance called IL-10, produced by bone marrow, affects the development of pancreatic fibrosis in mice. Researchers found that mice without IL-10 had significantly more collagen buildup (about 18.4%) and increased numbers of specific cells involved in tissue scarring compared to those with normal IL-10 levels. This research is important because it shows that IL-10 plays a key role in preventing harmful changes in the pancreas during inflammation, which can lead to more severe diseases. Who this helps: This helps patients with pancreatic diseases and doctors treating them.

PubMed

Regenerating the liver: not so simple after all?

2016

F1000Research

Alison MR, Lin WR

Plain English
This research examined how the liver regenerates after a significant part of it is removed and found that while certain liver cells called periportal hepatocytes play a major role in this process, other cells called pericentral hepatocytes are crucial for normal liver renewal. Specifically, the study revealed that pericentral cells help in everyday liver turnover, while in cases of injury, certain periportal cells can multiply significantly to aid recovery. This matters because understanding these complexities can lead to better treatments for liver diseases and injuries. Who this helps: Patients with liver damage or disease.

PubMed

Epidermal growth factor attenuates tubular necrosis following mercuric chloride damage by regeneration of indigenous, not bone marrow-derived cells.

2015

Journal of cellular and molecular medicine

Yen TH, Alison MR, Goodlad RA, Otto WR, Jeffery R +3 more

Plain English
This study looked at how two substances, epidermal growth factor (EGF) and pegylated granulocyte colony-stimulating factor (P-GCSF), affected healing in the kidneys of mice that experienced damage from mercuric chloride. The researchers found that EGF helped the kidneys recover better by encouraging the growth of the body’s own cells, which made up about 94% of the regenerating kidney tissue, while bone marrow cells played a minimal role. EGF treatment led to a significant increase in the growth of kidney cells—rising from 0.5% to 15% in the cell division phase—showing its importance for kidney repair after injury. Who this helps: This research benefits patients with acute kidney injury, particularly those affected by toxic substances.

PubMed

Regenerative medicine: Hepatic progenitor cells up their game in the therapeutic stakes.

2015

Nature reviews. Gastroenterology & hepatology

Alison MR, Lin WR

Plain English
This research studied liver cells known as hepatic progenitor cells (HPCs) and their ability to regenerate liver tissue. The results from experiments on mice showed that HPCs can significantly replace damaged liver cells, indicating they might be a promising option for treating liver failure. This discovery is important because it opens up new possibilities for better treatments for people with severe liver conditions. Who this helps: Patients with liver failure.

PubMed

Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice.

2015

Stem cell research & therapy

Banerjee A, Bizzaro D, Burra P, Di Liddo R, Pathak S +11 more

Plain English
This study looked at how human umbilical cord stem cells could help treat a bowel disease in mice that do not have a strong immune system. The researchers found that injecting these stem cells reduced disease symptoms: the level of inflammation decreased (from 2.08 to 1.45), colon length increased (from 6.8 cm to 8.95 cm), and overall disease severity also improved significantly. The findings suggest that umbilical cord stem cells may offer a new way to help manage inflammatory bowel diseases by targeting specific proteins involved in inflammation. Who this helps: This benefits patients with inflammatory bowel diseases and their doctors by providing a potential new treatment option.

PubMed

Regenerative medicine. Knocking on the door to successful hepatocyte transplantation.

2014

Nature reviews. Gastroenterology & hepatology

Forbes SJ, Alison MR

Plain English
This research focuses on finding ways to help patients who need liver transplants by exploring the use of liver cells, called hepatocytes, for treatment. The study highlights the challenges in getting enough of these cells for transplantation and emphasizes the need for methods to produce a steady supply of healthy liver cells that can grow over time. This is important because it could lead to better treatment options for people with liver diseases who currently face a shortage of donor organs. Who this helps: Patients with liver disease needing transplants.

PubMed

C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer.

2013

Pancreas

Al-Ghamdi S, Cachat J, Albasri A, Ahmed M, Jackson D +6 more

Plain English
This study focused on the C-terminal tensin-like gene (CTEN) and its role in pancreatic cancer. Researchers found that CTEN is present at high levels in 31 out of 44 pancreatic cancer samples, which is about 70%. They discovered that when CTEN levels were increased in certain cancer cells, those cells moved more easily, while reducing CTEN levels made them move less. This finding is important because it shows that CTEN contributes to the spread of pancreatic cancer, which could lead to new treatment approaches. Who this helps: This helps patients with pancreatic cancer by potentially informing new therapies.

PubMed

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.

2013

The Journal of pathology

Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR +2 more

Plain English
This research paper looks at the role of CD133, a protein found on some cancer cells, in identifying cancer stem cells in solid tumors. It discusses how CD133 could help in developing new cancer treatments but notes that current research shows mixed results, partly due to different methods used in studies. Understanding CD133 better could lead to improved cancer therapies, as it may reveal how tumors adapt and how the surrounding environment affects cancer growth. Who this helps: This helps patients with solid tumors and doctors looking for better ways to treat cancer.

PubMed

Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus.

2013

Gastroenterology

Pan Q, Nicholson AM, Barr H, Harrison LA, Wilson GD +10 more

Plain English
This study looked at special types of cells in the esophagus and stomach that might act like stem cells, meaning they can slowly grow and potentially help repair tissues. Researchers found these long-lived, slowly cycling cells in healthy parts of the esophagus and stomach but not in areas with diseases like dysplasia or cancer. This information is important because it adds to our understanding of how healthy tissues maintain themselves and may help in developing new treatments for esophageal diseases. Who this helps: This benefits patients with esophageal conditions, as well as doctors researching treatments.

PubMed

Liver cancer: Intrahepatic cholangiocarcinoma--appearances can be deceiving.

2013

Nature reviews. Gastroenterology & hepatology

Alison MR, Lin WR

PubMed

Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients.

2013

Gastroenterology research and practice

Wang J, El-Masry N, Talbot I, Tomlinson I, Alison MR +1 more

Plain English
This study looked at how certain proteins behave in patients with Familial Adenomatous Polyposis (FAP), a genetic condition that can lead to colon cancer. Researchers found that proteins associated with cell growth and death, like beta-catenin and Ki-67, were higher in early polyp stages and even more so in cancers, suggesting they play a role in the cancer development process. Specifically, beta-catenin and Ki-67 were significantly increased in adenomas and adenocarcinomas compared to normal tissue, helping to identify changes that occur as these growths develop. Who this helps: This research benefits patients with FAP by improving understanding of their disease and potentially guiding treatment decisions.

PubMed

What can be learnt about disease progression in breast cancer dormancy from relapse data?

2013

PloS one

Willis L, Graham TA, Alarcón T, Alison MR, Tomlinson IP +1 more

Plain English
This study looked at why breast cancer can come back many years after patients seem to be cancer-free. Researchers discovered that while we can’t pinpoint the exact changes that trigger this relapse, the patterns in long-term relapse data might indicate that certain treatments can actually increase the risk of relapse. Understanding these patterns is vital for improving how we monitor and treat breast cancer survivors. Who this helps: This helps doctors and breast cancer patients by informing treatment decisions and monitoring strategies.

PubMed

Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat.

2013

The American journal of pathology

Rizzo P, Perico N, Gagliardini E, Novelli R, Alison MR +2 more

Plain English
This study looked at how certain kidney cells react in cases of inflammation and damage, specifically focusing on a type of cell found in the Bowman's capsule of the kidney. Researchers found that in 36 kidney biopsies, the presence of CD133(+)CD24(+) progenitor cells was linked to kidney problems called proliferative glomerulonephritides, which involves abnormal cell growth. They discovered that signaling pathways involving certain receptors and chemicals in the kidney could promote the growth and movement of these cells in response to injury, indicating that targeting these pathways could help treat serious kidney conditions. Who this helps: This research benefits patients with severe kidney diseases, particularly those with proliferative glomerulonephritis.

PubMed

Transplanted hepatocytes: wiped out or washed out?

2012

Journal of hepatology

Alison MR, Marongiu F, Laconi E

PubMed

Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.

2012

Journal of gastrointestinal cancer

Wang J, Hollingshead J, El-Masry N, Horncastle D, Talbot I +3 more

Plain English
This study examined how certain proteins related to cancer (EGFR, HER2, pERK, and pMEK) are present in the colon tissue of patients with familial adenomatous polyposis (FAP), focusing on non-cancerous tissue, precancerous growths (adenomas), and cancerous tissues. The researchers found that EGFR was significantly more abundant in adenomas compared to non-cancerous tissue, while HER2 showed very little presence in any of the samples. This is important because it suggests that targeting EGFR and its signaling pathways could be a promising treatment option for patients with FAP, unlike HER2, which does not appear to contribute to cancer progression in these patients. Who this helps: Patients with familial adenomatous polyposis (FAP) may benefit from new treatments targeting EGFR.

PubMed

The ailing gut: a therapeutic role for bone marrow cells?

2012

Transplantation

Alison MR, Lin WR, Lee CY, Poulsom R, Wright NA +1 more

Plain English
This study looked at how bone marrow cells (BMCs) may help treat gut issues, especially inflammation. Researchers found that while BMCs don't play a significant role in minor gut injuries, they can contribute to healing during more severe, chronic problems. For instance, in cases of chronic gut inflammation, a small number of BMCs can integrate into the gut lining, which may help repair damage. Understanding how BMCs can aid in gut health is important because it could lead to new treatments for conditions like colitis. Who this helps: This research benefits patients with inflammatory bowel diseases.

PubMed

Bone marrow-derived cells contribute to cerulein-induced pancreatic fibrosis in the mouse.

2012

International journal of experimental pathology

Lin WR, Inatomi O, Lee CY, Kallis YN, Otto WR +3 more

Plain English
This study looked at how certain cells from bone marrow can turn into fibrous tissue cells in the pancreas of mice, which can lead to pancreatic damage. Researchers found that when they used bone marrow from mice with a specific genetic change, the resulting fibrous tissue was significantly worse—showing higher levels of collagen and more tissue damage—compared to normal bone marrow. This is important because it reveals that the origin of these cells can influence the severity of pancreatic fibrosis, which helps us understand how to potentially treat or prevent this condition. Who this helps: This helps doctors and researchers who treat and study pancreatic diseases.

PubMed

Trefoil factor family peptides in normal and diseased human pancreas.

2012

Pancreas

Guppy NJ, El-Bahrawy ME, Kocher HM, Fritsch K, Qureshi YA +5 more

Plain English
This study looked at special proteins called Trefoil Factor Family (TFF) peptides in healthy and diseased human pancreas tissues. Researchers found that TFF2 helps pancreatic cancer cells move and heal wounds, while TFF3 was present in many pancreatic cells but didn't promote cell growth as expected. Understanding how these proteins work is important because it could influence future treatments for pancreatic diseases, especially cancer. Who this helps: This research benefits doctors and researchers focusing on pancreatic diseases and cancer treatment.

PubMed

Cancer stem cells: in the line of fire.

2012

Cancer treatment reviews

Alison MR, Lin WR, Lim SM, Nicholson LJ

Plain English
This research paper examines cancer stem cells (CSCs), which are special cells within tumors that can keep growing and renewing themselves. It found that these cells are often resistant to treatments like chemotherapy and radiation, making them tough to eliminate. The study highlights several factors that contribute to this resistance and suggests new strategies for effectively targeting CSCs to improve cancer treatment outcomes. Who this helps: This helps patients with cancer by seeking better treatment options.

PubMed

Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials.

2012

Cell proliferation

Valorani MG, Montelatici E, Germani A, Biddle A, D'Alessandro D +7 more

Plain English
This study looked at how growing human fat tissue stem cells in low oxygen (2%) impacts their growth and ability to develop into fat and bone cells. The researchers found that cells grown in low oxygen grew better and stayed alive longer, and they were more likely to turn into fat and bone cells afterwards. This is important because it could improve treatments involving these stem cells in surgeries and tissue repair. Who this helps: This benefits patients undergoing plastic and reconstructive surgeries.

PubMed

Spheres of influence in cancer stem cell biology.

2011

The Journal of investigative dermatology

Perego M, Alison MR, Mariani L, Rivoltini L, Castelli C

PubMed

Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response.

2011

Gut

Kallis YN, Robson AJ, Fallowfield JA, Thomas HC, Alison MR +4 more

Plain English
This study examined how changes in a specific part of the liver, called the extracellular matrix (ECM), affect the liver's ability to heal itself after serious damage. Researchers found that when the ECM does not remodel properly, liver cells responsible for regeneration, called hepatic progenitor cells (HPCs), respond poorly to injury. In experiments, mice with a mutation affecting their ECM showed a significantly weaker HPC response—50-70% less effective recovery after injury—compared to normal mice. This finding highlights the important role of the ECM in liver healing. Who this helps: This research benefits patients with liver diseases by identifying potential targets for improving liver regeneration.

PubMed

Cancer stem cells: problems for therapy?

2011

The Journal of pathology

Alison MR, Lim SM, Nicholson LJ

Plain English
This 연구 focused on cancer stem cells (CSCs), a type of cell found in tumors that can replicate themselves and help tumors grow larger. The study found that CSCs can be identified and isolated using specific methods, and they can lead to more aggressive forms of cancer. Understanding these cells is crucial because they may pose a major challenge to effective cancer treatments if therapies only target one type of stem cell, as cancer can evolve different types over time. Who this helps: This information benefits patients and doctors by highlighting the complexities of cancer treatment and guiding more effective therapies.

PubMed

Hepatocyte turnover and regeneration: virtually a virtuoso performance.

2011

Hepatology (Baltimore, Md.)

Alison MR, Lin WR

Plain English
This research focused on how certain cells in the liver and pancreas develop and regenerate. The scientists found that a specific protein called Sox9 is important for the growth and repair of these organs, particularly during liver regeneration, indicating that certain cells responsible for making new liver cells come from Sox9-expressing progenitors. This matters because understanding how these cells work could improve treatments for liver damage and other related diseases. Who this helps: This helps patients with liver or pancreatic diseases.

PubMed

Chronic inflammation and hepatocellular carcinoma.

2011

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Alison MR, Nicholson LJ, Lin WR

Plain English
This study looked at how long-term inflammation in the liver can lead to a type of liver cancer called hepatocellular carcinoma (HCC). Researchers found that certain proteins and signals in the body, like NF-κB and IL-6, play important roles in this process. Understanding how inflammation contributes to HCC is crucial because it can help develop better treatments for those at risk. Who this helps: This helps patients at risk of liver cancer and doctors treating them.

PubMed

Bone marrow cells in murine colitis: multi-signal analysis confirms pericryptal myofibroblast engraftment without epithelial involvement.

2011

PloS one

Lee CY, Jeffery R, Hutchinson G, Alison MR, Poulsom R +2 more

Plain English
This study investigated whether bone marrow cells could replace the cells of the gut lining in mice with colitis, an inflammation of the colon. Researchers transplanted male bone marrow into female mice and induced colitis; however, they found no evidence of bone marrow cells becoming part of the gut lining, indicating that these cells do not fuse with gut epithelial cells. This is important because it clarifies the roles of different cell types in intestinal inflammation and shows that bone marrow transplants do not provide a way to repair damaged gut tissue in this context. Who this helps: This helps researchers and medical professionals understand the limits of bone marrow-derived therapies for gut diseases.

PubMed

Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.

2010

Cell cycle (Georgetown, Tex.)

Bortolomai I, Canevari S, Facetti I, De Cecco L, Castellano G +3 more

Plain English
This study looked at specific cancer cells from the A431 cervical carcinoma line to understand their cancer stem cell (CSC) characteristics. The researchers found that as these cells grew in clusters (or spheres), the proportion of CSCs increased from 46% to 65%, and these cells showed signs of being able to regenerate tumors, even with fewer cells. This is important because it provides insights into how some cancer cells can behave like stem cells and contribute to tumor growth, which could inform better treatment strategies. Who this helps: This research helps doctors and researchers working on cancer treatments.

PubMed

Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.

2010

The Journal of investigative dermatology

Perego M, Tortoreto M, Tragni G, Mariani L, Deho P +13 more

Plain English
This study looked at special groups of melanoma cells, called melanospheres, to understand their ability to start and grow tumors. The researchers found that just 100 of these melanosphere cells could create tumors in mice, and these tumors kept their ability to grow in new hosts. This is important because it shows that melanospheres are not only highly aggressive but also varied in their characteristics, which helps us understand how melanoma can be so different in patients. Who this helps: This helps researchers and doctors who are studying melanoma treatment options.

PubMed

Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver.

2010

Gut

Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K +8 more

Plain English
This study looked at how certain cells in the liver help repair damage in both lab mice and humans. Researchers found that a specialized area, or niche, filled with proteins and specific cells surrounds liver stem cells during injury, supporting their ability to regenerate. They discovered that one protein, laminin, plays a crucial role in keeping these stem cells undifferentiated, which is essential for liver repair. Who this helps: This benefits patients with liver disease by enhancing understanding of stem cell behaviors that could improve treatment outcomes.

PubMed

Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential.

2010

Cell and tissue research

Valorani MG, Germani A, Otto WR, Harper L, Biddle A +7 more

Plain English
Researchers studied mesenchymal stem cells (MSCs) from mouse fat tissues to see how low oxygen levels (hypoxia) affect their growth and ability to turn into fat cells. They found that when MSCs were grown in low oxygen (2% instead of 21%), they grew faster and had more cells expressing specific markers (Sca-1 and CD44). Importantly, these hypoxia-prepared cells had a greater potential to become fat cells when returned to normal oxygen conditions, showing enhanced activity of key genes involved in fat cell development. Who this helps: This helps patients needing fat tissue regeneration or treatments, as it improves methods for obtaining and using stem cells.

PubMed

Stem cells in cancer: instigators and propagators?

2010

Journal of cell science

Alison MR, Islam S, Wright NA

Plain English
This research paper examines the role of cancer stem cells (CSCs) in the development and spread of various cancers. The study found that CSCs are capable of both increasing in number as tumors grow and leading to the formation of new tumor cells that can invade surrounding tissues and spread to other parts of the body. This is significant because understanding how these cells work can improve cancer treatments and potentially lead to more effective therapies. Who this helps: This benefits patients by paving the way for better cancer treatment options.

PubMed

Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?

2010

The Journal of pathology

Alison MR, Guppy NJ, Lim SM, Nicholson LJ

Plain English
This research paper looks at a specific enzyme called aldehyde dehydrogenase (ALDH) to identify cancer stem cells, which are special cells that can help tumors grow. The study found that cancer stem cells, especially in breast cancer, often have high levels of ALDH, suggesting that testing for this enzyme can help spot these important cells. This is crucial because understanding which cells drive cancer growth can lead to better treatments and improve patient outcomes. Who this helps: This helps patients, especially those with breast cancer.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.